Policy & Regulation
11 May 2026 - Biopharmaceutical company Inhibrx Biosciences Inc (Nasdaq: INBX) on Monday reported positive interim results from the Phase 2 portion of its HexAgon study evaluating INBRX-106 in combina...
11 May 2026 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) on Monday reported updated positive survival observations from its ongoing Phase 1 trial of liraltagene autoleucel (lira-cel), ...
11 May 2026 - Oncopeptides AB (STO:ONCO), a Swedish biotech company focused on difficult-to-treat cancers, said on Monday that it intends to submit a Type II variation application to the European Medi...
11 May 2026 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Monday that it has entered an exclusive strategic collaboration with Sino Biopharmaceutical Limited through subsidiary Chia...
11 May 2026 - Chinese biopharmaceutical company Harbour BioMed (HKEX:02142) announced on Friday that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) applicatio...